Laurus Investment Counsel Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Integra LifeSciences
IART
|
+$2.54M |
| 2 |
EFOR
Everforth Inc
EFOR
|
+$2.41M |
| 3 |
Wabtec
WAB
|
+$186K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RP
RealPage, Inc.
RP
|
+$10.8M |
| 2 |
Emergent Biosolutions
EBS
|
+$6.99M |
| 3 |
Gartner
IT
|
+$1.5M |
| 4 |
Cooper Companies
COO
|
+$1.08M |
| 5 |
Generac Holdings
GNRC
|
+$1.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.25% |
| 2 | Financials | 21.51% |
| 3 | Healthcare | 20.21% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 6.68% |
Similar funds
Laurus Investment Counsel's Q2 2021 Portfolio in Review
As of Q2 2021, Laurus Investment Counsel held 49 positions worth $326M, up 25% from $260M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Laurus Investment Counsel withdrew a net $22M in Q2 2021, closing 12 positions and reducing 15 holdings. Its most notable exit was RealPage, Inc., an estimated $10.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 40% of assets, down from 41% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Laurus Investment Counsel opened a new position in Integra LifeSciences worth $3.04M.
- Laurus Investment Counsel's largest Q2 2021 buy was Integra LifeSciences: 35,933 shares worth $3.04M.
- Laurus Investment Counsel added most to Everforth Inc in Q2 2021, an estimated $2.41M increase.
- Laurus Investment Counsel's biggest Q2 2021 reduction was Gartner, cutting an estimated $1.5M.
- Laurus Investment Counsel fully exited RealPage, Inc. in Q2 2021, selling an estimated $10.8M.
- Laurus Investment Counsel's ten largest holdings make up 67% of its $326M portfolio in Q2 2021.
- Laurus Investment Counsel opened 2 new positions and closed 12 in Q2 2021.
- Laurus Investment Counsel's portfolio value rose 25% quarter-over-quarter to $326M.
Based on Laurus Investment Counsel's 13F filing for Q2 2021, filed 20 Jul 2021.